ORIGINAL RESEARCH article
Front. Med.
Sec. Pulmonary Medicine
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1609322
Disease burden and attributable risk factors for chronic obstructive pulmonary disease in China, Japan, and South Korea: Trends for 1990 to 2021 period and predictions for 2031
Provisionally accepted- 1Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China
- 2Qingdao University of Technology, Qingdao, Shandong, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Chronic obstructive pulmonary disease (COPD) is a key public health concern in East Asia. China, Japan, and South Korea represent important regions in East Asia, and the three countries have various similarities in terms of culture, economic development models, and population structure.Therefore, understanding the COPD burden in these three countries is crucial for the prevention and management of COPD in East Asian. Methods: Age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), agestandardized mortality rate (ASMR), age-standardized disability-adjusted life rate (ASDR), ageperiod-cohort (APC) analysis, and Bayesian age-period-cohort (BAPC) analysis data of COPD in China, Japan, and South Korea were collected and determined using the GBD (Global Burden of Disease) 2021 database.Results: China had the highest COPD burden between 1990 and 2021, followed by South Korea, and Japan. The dominant risk factor related to mortality rates and DALYs was environmental/occupational risks in China, whereas behavioral risks in Japan and South Korea were more significant. BAPC predictions indicated that the ASIR, ASPR, and ASDR for COPD in China, Japan, and South Korea would exhibit a downward trend between 2021 and 2031. However, the trend of the age-standardized mortality rate (ASMR) would vary among the three countries.Conclusions: Under the influence of environmental conditions, the aging population, economic development trends, and the construction of medical security systems, China, Japan, and South Korea share commonalities as well as differences in terms of COPD burden. China's actions concerning environmental protection have been effective, although reducing smoking rates and alleviating the pollution caused by industrialization are crucial for further reducing the COPD burden in China. Owing to Japan's environmental protection policies, low smoking rates, and comprehensive social security measures, the COPD burden in Japan is relatively low compared to that in China and South Korea.Owing to the impact of environmental pollution, imperfections in the medical security system, and the influence of South Korea's handling of related issues after the economic rise of the nation, the COPD burden in South Korea has undergone significant fluctuations.
Keywords: East Asian, GBD database, chronic obstructive pulmonary disease, disease burden, ageperiod-cohort analysis, Bayesian age-period-cohort analysis
Received: 10 Apr 2025; Accepted: 29 Aug 2025.
Copyright: © 2025 Wang, Zhu, Wang and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jihong Zhou, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.